Economic TimesLean R·
Alembic Pharma gets USFDA nod for cancer drug
New Delhi: Alembic Pharmaceuticals Ltd on Friday said it has received tentative approval from the US health regulator for its generic version of cancer treatment drug Binimetinib tablets.The tentative approval by the US Food & Drug Administration (USFDA) is for the Abbreviated New Drug Application (ANDA) of Binimetinib tablets of strength 45 mg, Alembic Pharmaceuticals said in a regulatory filing.Based on USFDA's paragraph IV certifications list, Alembic is the sole first applicant to have …
Read at Economic Times →
